Complement Inhibition with Eculizumab in Patients with Cold Agglutinin Disease (CAD): Results from a Prospective Phase II Trial (DECADE Trial)
暂无分享,去创建一个
A. Hüttmann | U. Dührsen | H. Schrezenmeier | N. Kuklik | M. Bommer | A. Röth | Doerte Herich-Terhuerne | Lenz Veronika